Literature DB >> 2953259

Atrial natriuretic factor decreases whole-body capillary absorption in rats.

N C Trippodo, R W Barbee.   

Abstract

Previous studies suggested that exogenous atrial natriuretic factor (ANF) altered extracellular fluid partition between plasma and interstitium. The effect of ANF and a similarly effective diuretic dose of furosemide on whole-body transcapillary fluid movement was studied in anesthetized rats by measuring changes in urine and plasma volumes, while accounting for the volume of fluid administered. After 75 min of infusion, urine volume was 9.9 +/- 1.0 ml/kg in rats receiving ANF (0.5 micrograms X min-1 X kg-1), and plasma volume decreased by 3.7 ml/kg (P less than 0.01) compared with rats receiving vehicle only. In the furosemide rats, urine volume was 12.3 +/- 1.9 ml/kg, yet plasma volume was not significantly different from that in the vehicle rats. These results suggested that unlike furosemide, which allowed sufficient capillary absorption to maintain plasma volume constant despite the large diuresis, ANF attenuated whole-body net capillary absorption. The effect of ANF on capillary absorption was quantitated in anephric rats by measuring the increase in plasma volume after intravenous administration of hyperoncotic albumin. After accounting for the volume administered, whole-body net capillary absorption was less (P less than 0.05) in the rats receiving ANF (4.8 +/- 0.4 ml/kg) than in those receiving vehicle (5.9 +/- 0.2 ml/kg). Plasma protein concentration was greater in other anephric rats receiving a similar ANF infusion than in those receiving vehicle. These findings suggest that ANF decreased capillary absorption because of increased average capillary hydrostatic pressure and not because of altered capillary permeability.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2953259     DOI: 10.1152/ajpregu.1987.252.5.R915

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Atrial natriuretic factor increases splenic microvascular pressure and fluid extravasation in the rat.

Authors:  R Sultanian; Y Deng; S Kaufman
Journal:  J Physiol       Date:  2001-05-15       Impact factor: 5.182

2.  Atriopeptin inhibition of thrombin-mediated changes in the morphology and permeability of endothelial monolayers.

Authors:  D A Baron; C E Lofton; W H Newman; M G Currie
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

3.  Volume status influences atrial peptide-induced water conductivity changes in leopard frog mesenteric capillaries.

Authors:  D J Meyer; V H Huxley; M K McKay
Journal:  J Physiol       Date:  1992-02       Impact factor: 5.182

4.  Influence of atrial natriuretic factor on fluid efflux from the splenic circulation of the rat.

Authors:  Y Deng; S Kaufman
Journal:  J Physiol       Date:  1996-02-15       Impact factor: 5.182

5.  Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation.

Authors:  M R Wilkins; S L Settle; P Needleman
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 6.  Endothelial actions of atrial and B-type natriuretic peptides.

Authors:  Michaela Kuhn
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

7.  Atrial natriuretic peptide modulation of albumin clearance and contrast agent permeability in mouse skeletal muscle and skin: role in regulation of plasma volume.

Authors:  Fitz-Roy E Curry; Cecilie Brekke Rygh; Tine Karlsen; Helge Wiig; Roger H Adamson; Joyce F Clark; Yueh-Chen Lin; Birgit Gassner; Frits Thorsen; Ingrid Moen; Olav Tenstad; Michaela Kuhn; Rolf K Reed
Journal:  J Physiol       Date:  2009-11-30       Impact factor: 5.182

8.  Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.

Authors:  M R Wilkins; S L Settle; J E Kirk; S A Taylor; K P Moore; R J Unwin
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

9.  Atrial natriuretic peptide attenuates flow in an isolated lymph duct preparation.

Authors:  D J Atchison; M G Johnston
Journal:  Pflugers Arch       Date:  1996-02       Impact factor: 3.657

10.  Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion.

Authors:  S Adnot; P Andrivet; P E Chabrier; J Piquet; P Plas; P Braquet; F Roudot-Thoraval; C Brun-Buisson
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.